News · Everus Construction Group, Inc. (ECG) · Industrials

Everus Construction falls 29.3% after quarterly results and guide raise

Session of November 4, 2026 · Published November 5, 2026 · 4 min read

What happened

Everus Construction (ECG) fell 29.3% on November 4, 2026, after it reported third-quarter results and raised its 2026 guidance, prompting a sharp market re-pricing following an investor call. Business Wire and Seeking Alpha reported the company’s Q3 numbers and management’s commentary. The stock opened 11.5% below the previous close and trading volume was 5.2 times its 20-day average as investors quickly re-priced the shares. The stock’s market value was $5.24 billion on the session.

Closing price over the last 30 trading sessions. On November 4, 2026, ECG closed at $79.71, down 29.3% on the day and 31.7% lower than 30 sessions earlier.

How big was the move

The session’s change was 5.3 times a typical daily move for this stock, a large move by its standards. It underperformed its sector by 29.3 percentage points, while the Industrials sector median was unchanged on the day. The S&P 500 rose 1.6% that session; over the last five sessions Everus Construction fell 24.7% while the S&P 500 fell 0.7%. With a beta of 1.55, the stock tends to move more than the market, magnifying the reaction to the earnings release. The opening gap and volume spike suggest traders re-priced risk fast rather than awaiting further news.

Each bar is one day's price change; the outlined bar is November 4, 2026. A typical daily move over the past year was 4.0%, so the latest move equals 7.3 times that. Moves outside the dashed lines (about 8.0%) are unusual.

The technical picture

Technically the stock looked weak after the decline. The stock was 25.6% below its 20-day moving average and 29.7% below its 50-day moving average, with the 50-day average below the 200-day average, a sign of a weak longer-term trend. It was 36.7% below its 200-day moving average and 53.5% below the 52-week high. The Relative Strength Index (14 days) read 30, in the neutral range between 30 and 70, which suggests the shares had moved quickly toward oversold territory but had not yet registered an extreme reading. Volatility was 88% annualized over 60 days, the highest reading of the past five years, reflecting unusually elevated price swings.

Closing price over the past year. ECG ends the period 52.9% below its 52-week high, below its 50-day average ($113.36) and below its 200-day average ($125.97).

Price performance showed sharp recent weakness: the stock fell 40.0% over one month and 42.9% over three months, and was down 11.7% over one year, trailing the S&P 500 by 23.9 percentage points. Those trends help explain why the market reaction to apparently positive results was so pronounced: momentum was weak heading into the report, leaving the stock vulnerable to a directional re-rate.

Fundamentals and valuation

On fundamentals, Everus showed rapid top-line and profit growth over the four quarters through September 30, 2026. The company reported revenue of $4.66 billion, which grew 33.5% from a year earlier, and diluted earnings per share of $5.65, which rose 60.1% year-over-year. Gross margin improved to 13.6% from 12.1% a year earlier, and operating margin widened to 8.2% from 6.9%. Free-cash-flow margin stood at 5.1% and return on invested capital was 20.9%.

Quarterly revenue by period end. The latest quarter brought $1.4B, 40.3% more than the same quarter a year earlier.

The balance sheet showed net debt of 1.0 times EBITDA and share count over one year increased by 0.2%. Valuation metrics looked subdued relative to the company’s recent history: the stock traded at 14.1 times trailing earnings, the lowest reading of the past five years, versus a five-year median of 21.6 times earnings. Price to forward earnings was 15.0 times expected earnings and free-cash-flow yield was 4.5%.

PromtFinance scores highlighted the contrast between operating strength and weak price action. Everus ranked high on Value at 94 and Growth at 92, while Momentum was weak at 24 and Stability was weak at 26. Those contrasts underline a firm with strong recent operating performance and a low historical P/E but poor price momentum and heightened volatility.

Earnings and analyst expectations

Everus reported last on November 3, 2026, posting diluted earnings per share of $1.79 against $1.31 expected, 36.6% above estimates, and that marked the seventh consecutive quarter beating estimates. The company reported Q3 revenues of $1.38 billion, a 40.3% increase versus the year-ago period, net income of $91.9 million, up 61.2%, and a net income margin of 6.6%, according to Business Wire and Seeking Alpha. Management held an earnings call on November 4, 2026, to discuss the quarter and raise 2026 guidance; the market’s swift reaction suggests investors focused on guidance detail, tone or nearer-term risks rather than the beat itself.

Diluted earnings per share by quarter. The latest quarter shows $1.79, against $1.11 in the same quarter a year earlier.

Over the last four reports the average surprise was 45.1% above estimates and the typical two-day reaction after recent reports was a rise of 3.2%. Six analysts cover the stock, with a consensus rating of Buy and 67% of ratings at Buy or Strong Buy. The consensus price target is $175.20, which is 119.8% above the closing price on the session. That divergence between analyst targets and the immediate market reaction highlights tension between longer-term earnings expectations and short-term risk sentiment.

What to watch

February 23, 2027: next scheduled earnings report.
November 3, 2026: last report showed earnings per share of $1.79 against $1.31 expected and revenue of $1.38 billion, reported by Business Wire and Seeking Alpha.
PromtFinance scores: Value 94, Growth 92, Momentum 24; watch whether momentum metrics improve.
Valuation versus history: 14.1 times trailing earnings, the lowest reading of the past five years.

Full ECG analysis: scores, chart and financials →